New study aims to decode cancer risk in treated thyroid nodules
NCT ID NCT05726981
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 180 people who had a benign thyroid nodule treated with radiofrequency heat ablation three years ago. Researchers will use ultrasound and a fine-needle biopsy to see how the nodule looks and whether any cells have changed. The goal is to create a better way to spot cancer in these treated nodules, since current ultrasound rules don't apply well after ablation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiofrequency thermal ablation
What this could lead to
If successful, this could create a new ultrasound-based system to better predict cancer risk in treated thyroid nodules, reducing unnecessary biopsies.
What could go wrong
This is an early exploratory study with no control group, so results may not apply to all patients. The findings are descriptive and may not change current practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN THYROID NODULES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Pitié-Salpêtrière - Department of Thyroid and Endocrine Tumour Pathologies
RECRUITINGParis, 75651, France
Contact Phone: •••-•••-•••• Email: •••••@•••••